GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Indoco Remedies Ltd

Indoco Remedies Ltd Allots 14,850 Shares Under ESOP Plan

FUNDRAISE ● No Immediate Change LOW RISK
📅 Filed on BSE: 27 Oct 2026, 10:01 AM IST  ·  BSE ID: 7e222142-b70e-4fe9-81d4-f6b647c30991
View Original BSE Filing (PDF)
💡
In Simple Terms
The company issued new shares to its employee stock plan trust, slightly increasing its total number of shares and capital.
🤖 AI Summary
  • Indoco Remedies approved allotment of 14,850 equity shares under its 2022 ESOP Plan.
  • Shares are issued to the Indoco Employees Welfare Trust for future employee allocation.
  • Allotment increases paid-up capital by Rs. 29,700.
  • Company's total equity shares now stand at 9,23,18,455.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Allotted
14,850
Issue Price per Share
Rs. 2
Total Amount Received
Rs. 29,700
Previous Paid-up Capital
Rs. 18,46,07,210
New Paid-up Capital
Rs. 18,46,36,910
Previous Equity Shares
9,23,03,605
New Equity Shares
9,23,18,455
🏢 How This Affects the Company
💰
Financial Impact
The allotment of 14,850 equity shares increases the company's paid-up share capital by Rs. 29,700.
👥 What This Means For Shareholders
✅
Action Required
No action is required from existing shareholders.
👤
Who Is Affected
This impacts all existing shareholders through a minor dilution of ownership percentage.
🔍
Management Signal
This decision demonstrates management's ongoing commitment to the Employee Stock Option Plan – 2022.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next quarterly results announcement for updated share capital figures.
Future ESOP exercises impacting share count.
Announcements regarding the utilization of ESOP Trust funds.
LOW RISK Routine ESOP allotment with minimal financial impact and no new business risks.
💡 Investor Takeaway
Indoco Remedies allotted 14,850 equity shares under its 2022 ESOP Plan to its employee trust, increasing paid-up capital by Rs. 29,700, with total shares now 9,23,18,455.
⚖️ Strengths & Concerns

✅ Positives

  • Company actively utilizes ESOP plan to incentivize employees with equity issuance.
  • Allotment is a routine part of employee compensation under approved stock option plan.
❓ Frequently Asked Questions
What did Indoco Remedies Limited's Nomination and Remuneration Committee approve on October 27, 2026?
The committee approved the allotment of 14,850 equity shares to the Indoco Employees Welfare Trust under the 2022 ESOP Plan.
How many shares were allotted under the Indoco Remedies Limited Employee Stock Option Plan – 2022?
A total of 14,850 equity shares were allotted at an issue price of Rs. 2 per share, amounting to Rs. 29,700.
How does this allotment affect Indoco Remedies' paid-up capital and share count?
The allotment increased the paid-up capital from Rs. 18,46,07,210 to Rs. 18,46,36,910 and the equity shares from 9,23,03,605 to 9,23,18,455.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.